Literature DB >> 31723042

Dysregulation of different classes of tRNA fragments in chronic lymphocytic leukemia.

Dario Veneziano1,2, Luisa Tomasello1,2, Veronica Balatti1,2, Alexey Palamarchuk1,2, Laura Z Rassenti3, Thomas J Kipps3, Yuri Pekarsky4,2, Carlo M Croce4,2.   

Abstract

Chronic lymphocytic leukemia (CLL) is the most common human leukemia, and dysregulation of tRNA-derived short noncoding RNA (tsRNA) (tRF-1) expression is an accompanying event in the development of this disease. tsRNAs are fragments originating from the 3' end of tRNA precursors and do not contain mature tRNA sequences. In contrast to tsRNAs, mature tRFs (tRF-3s, tRF-5s, and internal tRFs) are produced from mature tRNA sequences and are redundant fragments. We investigated tsRNA expression in CLL and determined tsRNA signatures in indolent CLL and aggressive CLL vs. normal B cells. We noticed that both ts-43 and ts-44 are derived from distinct genes of pre-tRNAHis, and are down-regulated in CLL 3- to 5-fold vs. normal B cells. Thus, we investigated expression levels of tRF-5 fragments from tRNAHis in CLL samples and healthy controls, and determined that such fragments are down-regulated by 5-fold in CLLs vs. normal controls. Given these results, we investigated the expression of all mature tRFs in CLLs vs. normal controls. We found a drastic dysregulation of the expression of mature tRFs in CLL. In aggressive CLL, for the top 15 up-regulated fragments, linear fold change varied from 2,053- to 622-fold. For the top 15 down-regulated fragments in CLL, linear fold change varied from 314- to 52-fold. In addition, 964 mature tRFs were up-regulated at least 2-fold in CLL, while 701 fragments were down-regulated at least 2-fold. Similar results were obtained for indolent CLL. Our results suggest that mature tRFs may have oncogenic and/or tumor suppressor function in CLL.

Entities:  

Keywords:  tRFs; tRNA fragments; tsRNAs

Mesh:

Substances:

Year:  2019        PMID: 31723042      PMCID: PMC6883801          DOI: 10.1073/pnas.1913695116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  dbSNP: the NCBI database of genetic variation.

Authors:  S T Sherry; M H Ward; M Kholodov; J Baker; L Phan; E M Smigielski; K Sirotkin
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia.

Authors:  Veronica Balatti; Lara Rizzotto; Cecelia Miller; Alexey Palamarchuk; Paolo Fadda; Rosantony Pandolfo; Laura Z Rassenti; Erin Hertlein; Amy S Ruppert; Arletta Lozanski; Gerard Lozanski; Thomas J Kipps; John C Byrd; Carlo M Croce; Yuri Pekarsky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

3.  TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state.

Authors:  M Herling; K A Patel; J Khalili; E Schlette; R Kobayashi; L J Medeiros; D Jones
Journal:  Leukemia       Date:  2006-02       Impact factor: 11.528

4.  IL-4 Inhibits the Biogenesis of an Epigenetically Suppressive PIWI-Interacting RNA To Upregulate CD1a Molecules on Monocytes/Dendritic Cells.

Authors:  Xue Zhang; Xin He; Chao Liu; Jun Liu; Qifei Hu; Ting Pan; Xiaobing Duan; Bingfeng Liu; Yiwen Zhang; Jingliang Chen; Xingru Ma; Xu Zhang; Haihua Luo; Hui Zhang
Journal:  J Immunol       Date:  2016-01-11       Impact factor: 5.422

5.  Accurate Profiling and Quantification of tRNA Fragments from RNA-Seq Data: A Vade Mecum for MINTmap.

Authors:  Phillipe Loher; Aristeidis G Telonis; Isidore Rigoutsos
Journal:  Methods Mol Biol       Date:  2018

6.  Genomic aberrations and survival in chronic lymphocytic leukemia.

Authors:  H Döhner; S Stilgenbauer; A Benner; E Leupolt; A Kröber; L Bullinger; K Döhner; M Bentz; P Lichter
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

7.  Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.

Authors:  Roberta Bichi; Susan A Shinton; Eric S Martin; Anatoliy Koval; George A Calin; Rossano Cesari; Giandomenico Russo; Richard R Hardy; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

8.  Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement.

Authors:  Hani Goodarzi; Xuhang Liu; Hoang C B Nguyen; Steven Zhang; Lisa Fish; Sohail F Tavazoie
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

9.  ConDeTri--a content dependent read trimmer for Illumina data.

Authors:  Linnéa Smeds; Axel Künstner
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

10.  MINTmap: fast and exhaustive profiling of nuclear and mitochondrial tRNA fragments from short RNA-seq data.

Authors:  Phillipe Loher; Aristeidis G Telonis; Isidore Rigoutsos
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

View more
  19 in total

1.  Serum tRNA-derived small RNAs as potential novel diagnostic biomarkers for pancreatic ductal adenocarcinoma.

Authors:  Meilin Xue; Minmin Shi; Junjie Xie; Jun Zhang; Lingxi Jiang; Xiaxing Deng; Chenghong Peng; Baiyong Shen; Hong Xu; Hao Chen
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

Review 2.  tRNA-derived fragments (tRFs) in cancer.

Authors:  Yuri Pekarsky; Veronica Balatti; Carlo M Croce
Journal:  J Cell Commun Signal       Date:  2022-08-29       Impact factor: 5.908

3.  Opposite regulation of piRNAs, rRNAs and miRNAs in the blood after subarachnoid hemorrhage.

Authors:  Rafal Morga; Malgorzata Borczyk; Michal Korostynski; Marcin Piechota; Dzesika Hoinkis; Slawomir Golda; Tomasz Dziedzic; Agnieszka Slowik; Marek Moskala; Joanna Pera
Journal:  J Mol Med (Berl)       Date:  2020-05-18       Impact factor: 4.599

Review 4.  tRNA-derived RNA fragments in cancer: current status and future perspectives.

Authors:  Mengqian Yu; Bingjian Lu; Jisong Zhang; Jinwang Ding; Pengyuan Liu; Yan Lu
Journal:  J Hematol Oncol       Date:  2020-09-04       Impact factor: 17.388

Review 5.  Non-Coding RNAs as Mediators of Epigenetic Changes in Malignancies.

Authors:  Subhasree Kumar; Edward A Gonzalez; Pranela Rameshwar; Jean-Pierre Etchegaray
Journal:  Cancers (Basel)       Date:  2020-12-05       Impact factor: 6.639

6.  tsRBase: a comprehensive database for expression and function of tsRNAs in multiple species.

Authors:  Yuanli Zuo; Lei Zhu; Zhixin Guo; Wenrong Liu; Jiting Zhang; Zhen Zeng; Qingbin Wu; Jian Cheng; Xin Fu; Yang Jin; Yun Zhao; Yong Peng
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

7.  Extensive profiling of the expressions of tRNAs and tRNA-derived fragments (tRFs) reveals the complexities of tRNA and tRF populations in plants.

Authors:  Xuan Ma; Chunyan Liu; Xiaocong Kong; Jing Liu; Siju Zhang; Shanshan Liang; Weijiang Luan; Xiaofeng Cao
Journal:  Sci China Life Sci       Date:  2021-02-08       Impact factor: 6.038

Review 8.  Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia.

Authors:  Felice Pepe; Veronica Balatti
Journal:  J Clin Med       Date:  2020-02-21       Impact factor: 4.241

9.  Comprehensive profiling of extracellular RNA in HPV-induced cancers using an improved pipeline for small RNA-seq analysis.

Authors:  Fangjia Tong; Arlise Andress; Gongyu Tang; Ping Liu; Xiaowei Wang
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

10.  Plasma tRNA Fragments Derived from 5' Ends as Novel Diagnostic Biomarkers for Early-Stage Breast Cancer.

Authors:  Jingyi Wang; Ge Ma; Minghui Li; Xu Han; Jin Xu; Mengdi Liang; Xinrui Mao; Xiang Chen; Tiansong Xia; Xiaoan Liu; Shui Wang
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-23       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.